UnitedHealth Group Incorporated (UNH) is listed on NYSE in the Healthcare sector Β· Healthcare Plans industry. The current price is 404.49, up 1.21% from the previous close. Market cap is approximately $358.7B.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
UnitedHealth Group Incorporated trades at a premium P/E of 25.67x, with a lot of growth priced in. A single quarter that misses consensus can compress the multiple sharply.
ROE of 14.15% is around the market median. Comparing to the industry-specific median tells you the relative read.
D/E of 69.21 indicates high leverage. Watch interest coverage and free cash flow closely, especially across rate cycles.
UnitedHealth Group Incorporated is growing revenue at 0.40% annually. The interesting question is whether pricing power is lifting margins to compensate for the modest top-line.
UnitedHealth Group Incorporated's 2.34% yield is standard. If the company is also buying back stock, evaluate on total shareholder return (dividends + buybacks) rather than yield alone.
Pharma and biotech are typically valued through risk-adjusted NPV/DCF on the pipeline.
UnitedHealth Group Incorporated trades in the upper 28% of its 52-week range (255.97β461.62). The uptrend is intact, though how much optimism is already reflected in the price is a separate question worth checking.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app
The stock moved within a 2.49% high-to-low band on the day, closing 1.21%. That falls within a typical intraday range.
UnitedHealth Group Incorporated (UNH) is listed on NYSE, with recent volume of 1,204,353 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.